Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results from an International Multicenter Study

Researchers evaluated the role of adjuvant chemotherapy in intraductal papillary mucinous neoplasm (IPMN)-derived PDAC, reporting that almost half of patients with resected IPMN-derived PDAC may be overtreated or undertreated.